47
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The cytoplasmic mislocalization and aggregation of TAR DNA-binding protein-43 (TDP-43) is a common histopathological hallmark of the amyotrophic lateral sclerosis and frontotemporal dementia disease spectrum (ALS/FTD). However, the composition of aggregates and their contribution to the disease process remain unknown. Here, we used proximity-dependent biotin identification (BioID) to interrogate the interactome of detergent-insoluble TDP-43 aggregates, and found them enriched for components of the nuclear pore complex (NPC) and nucleocytoplasmic transport machinery. Aggregated and disease-linked mutant TDP-43 triggered the sequestration and/or mislocalization of nucleoporins (Nups) and transport factors (TFs), and interfered with nuclear protein import and RNA export in mouse primary cortical neurons, human fibroblasts, and iPSC-derived neurons. Nuclear pore pathology is present in brain tissue from sporadic ALS cases (sALS) and those with genetic mutations in TARDBP (TDP-ALS) and C9orf72 (C9-ALS). Our data strongly implicate TDP-43-mediated nucleocytoplasmic transport defects as a common disease mechanism in ALS/FTD.

          Related collections

          Most cited references43

          • Record: found
          • Abstract: found
          • Article: not found

          Directed evolution of APEX2 for electron microscopy and proteomics

          APEX is an engineered peroxidase that functions both as an electron microscopy tag, and as a promiscuous labeling enzyme for live-cell proteomics. Because the limited sensitivity of APEX precludes applications requiring low APEX expression, we used yeast display evolution to improve its catalytic efficiency. Our evolved APEX2 is far more active in cells, enabling the superior enrichment of endogenous mitochondrial and endoplasmic reticulum membrane proteins and the use of electron microscopy to resolve the sub-mitochondrial localization of calcium uptake regulatory protein MICU1.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention.

            A hexanucleotide GGGGCC repeat expansion in the noncoding region of the C9ORF72 gene is the most common genetic abnormality in familial and sporadic amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The function of the C9ORF72 protein is unknown, as is the mechanism by which the repeat expansion could cause disease. Induced pluripotent stem cell (iPSC)-differentiated neurons from C9ORF72 ALS patients revealed disease-specific (1) intranuclear GGGGCCexp RNA foci, (2) dysregulated gene expression, (3) sequestration of GGGGCCexp RNA binding protein ADARB2, and (4) susceptibility to excitotoxicity. These pathological and pathogenic characteristics were confirmed in ALS brain and were mitigated with antisense oligonucleotide (ASO) therapeutics to the C9ORF72 transcript or repeat expansion despite the presence of repeat-associated non-ATG translation (RAN) products. These data indicate a toxic RNA gain-of-function mechanism as a cause of C9ORF72 ALS and provide candidate antisense therapeutics and candidate human pharmacodynamic markers for therapy. Copyright © 2013 Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Protein disorder prediction: implications for structural proteomics.

              A great challenge in the proteomics and structural genomics era is to predict protein structure and function, including identification of those proteins that are partially or wholly unstructured. Disordered regions in proteins often contain short linear peptide motifs (e.g., SH3 ligands and targeting signals) that are important for protein function. We present here DisEMBL, a computational tool for prediction of disordered/unstructured regions within a protein sequence. As no clear definition of disorder exists, we have developed parameters based on several alternative definitions and introduced a new one based on the concept of "hot loops," i.e., coils with high temperature factors. Avoiding potentially disordered segments in protein expression constructs can increase expression, foldability, and stability of the expressed protein. DisEMBL is thus useful for target selection and the design of constructs as needed for many biochemical studies, particularly structural biology and structural genomics projects. The tool is freely available via a web interface (http://dis.embl.de) and can be downloaded for use in large-scale studies.
                Bookmark

                Author and article information

                Journal
                9809671
                21092
                Nat Neurosci
                Nat. Neurosci.
                Nature neuroscience
                1097-6256
                1546-1726
                30 November 2017
                08 January 2018
                February 2018
                01 August 2018
                : 21
                : 2
                : 228-239
                Affiliations
                [1 ]Department of Cell Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
                [2 ]Department of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA
                [3 ]Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA
                [4 ]Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA
                [5 ]Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
                [6 ]Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, GA 30322, USA
                [7 ]Emory ALS Center, Emory University School of Medicine, Atlanta, GA 30322, USA
                [8 ]Department of Pathology and Immunology, Washington University, St. Louis, MO 63110, USA
                [9 ]Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA
                [10 ]Department of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224 USA
                [11 ]Department of Neurobiology, Barrow Neurological Institute, Phoenix, AZ 85013, USA
                [12 ]Department of Molecular & Cellular Biology, University of Arizona, Tucson, AZ 85721, USA
                [13 ]Xiangya Hospital and Xiangya School of Medicine, Central South University, Changsha, Hunan, China
                [14 ]Department of Ophthalmology, the Second Hospital of Jilin University, Changchun, China
                Author notes
                Correspondence should be addressed to W.R. ( Rossoll.Wilfried@ 123456mayo.edu )
                [15]

                Present address: Department of Biology, Stanford University, Stanford, CA 94305, USA.

                [16]

                Present address: Max Planck Institute for Brain Research, 60438 Frankfurt, Germany

                [17]

                Present address: Department of Respiratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.

                [18]

                These authors contributed equally to this work.

                Article
                NIHMS920163
                10.1038/s41593-017-0047-3
                5800968
                29311743
                2f1973ee-7d2b-4759-857f-8e375142aa0b

                Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Categories
                Article

                Neurosciences
                Neurosciences

                Comments

                Comment on this article